...的挽救治疗及造血干细胞移植治疗一、挽救治疗1、单药化疗曾应用烷化剂治疗的慢性淋巴细胞白血病（chronic lymphocytic leukemia，CLL）患者复发，再次应用烷化剂治疗缓解率22%-62%，但多数患者缓解持续时间短，仅极少数患者可达完全缓解...
基于2个网页-相关网页
Rituxan现在已经被批准用于非霍奇金淋巴瘤、慢性淋巴细胞白血病和风湿性关节炎的治疗。
Rituxan is currently approved as a treatment for non-Hodgkin's lymphoma, chronic lymphocytic leukemia and rheumatoid arthritis.
与其他三种类型的白血病不同，慢性淋巴细胞白血病患者可能会有一些持续时间不长的病症。
Unlike the other three types of leukemia, some patients with CLL may have disease that does not progress for a long time.
有些病人在常规体检的血液检查后才知道他们患有慢性淋巴细胞白血病或慢性粒细胞性白血病。
Some patients learn they have CLL or CML after a blood test as part of a regular checkup.
应用推荐